Ciencias de la vida

Fremgangsmåde
15/12/2025
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
18/12/2025 - The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a...
CANCER THERAPY WITH TGF-BETA-2 AND IRINOTECAN AGENTS
18/12/2025 - This invention describes methods for treating or ameliorating the symptoms of cancer in a subject with agents, compositions and regimens designed to promote anti-tumor effects and avoid drug...
SIRNA TARGETING RECQL1 HELICASE GENE
18/12/2025 - An siRNA targeting RecQL1 helicase gene, based on a target sequence, is provided having a superior effect as compared to conventional siRNAs. The siRNA targeting RecQL1 helicase gene includes a...
METHODS OF USING EXTRACELLULAR VESICLE-ASO TARGETING STAT6
18/12/2025 - The present disclosure relates to methods of administering an antisense oligonucleotide (ASO) comprising a contiguous nucleotide sequence of 10 to 30 nucleotides in length that is complementary to...
METHODS AND COMPOSITIONS FOR SYNTHESIS OF THERAPEUTIC NANOPARTICLES
18/12/2025 - Improved methods and reactants for the chemical synthesis of therapeutic nanoparticles are provided. The nanoparticles comprise a polymeric core, to which is attached one or more homing molecules...
CELL CULTURE METHOD
18/12/2025 - The present invention aims to provide a method that makes it possible to sufficiently proliferate cells, particularly immunocompetent cells, even in a serum-free medium or low-serum medium, and a...
DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS
18/12/2025 - The invention provides for delivery, engineering and optimization of systems, methods and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery...